GHRP-2 is one of the original synthetic growth hormone-releasing peptides — developed in the late 1980s and early 1990s as part of a research program to find stable GH secretagogues. It activates the ghrelin receptor (GHSR) on pituitary somatotrophs to stimulate GH release, producing one of the strongest acute GH responses of any secretagogue in the class. It's also used clinically as a diagnostic tool — the GHRP-2 stimulation test is a validated diagnostic test used in endocrinology to assess pituitary GH reserve.
GHRP-2's defining characteristic is potency. It produces robust, reliable GH spikes — peak GH elevations consistently among the highest of any GH secretagogue tested in humans. The trade-off is selectivity: like GHRP-6 and MK-677, GHRP-2 activates ghrelin pathways broadly, producing meaningful cortisol and prolactin elevation alongside GH. Ipamorelin was specifically engineered to avoid these secondary effects — GHRP-2 was not.
In biohacker communities, GHRP-2 is typically discussed as part of a CJC-1295 + GHRP-2 stack — the dual-receptor approach combining GHRH receptor stimulation (CJC-1295) with ghrelin receptor stimulation (GHRP-2) for synergistic GH elevation. Many biohackers who want maximal GH elevation prefer GHRP-2 over ipamorelin for this stack, accepting the cortisol/prolactin trade-off in exchange for stronger GH pulses.
How it works
GHSR Agonism and GH Release
GHRP-2 binds the ghrelin receptor (GHS-R1a) on anterior pituitary somatotroph cells, activating intracellular calcium signaling and directly stimulating GH granule exocytosis. It also acts at the hypothalamic level to stimulate GHRH release and suppress somatostatin (the GH-inhibiting hormone), creating a triple amplification: pituitary GH release + GHRH stimulation + somatostatin suppression. This combination is why GHRP-2 produces larger GH responses than compounds acting through only one mechanism.
Cortisol and Prolactin Elevation
GHSR activation also stimulates ACTH release, which drives cortisol from the adrenal glands, and prolactin release from lactotroph cells. These effects are dose-dependent and real — documented in human studies. For short-term, intermittent protocols, the cortisol effect is generally manageable. For long-term daily use, sustained cortisol elevation is a legitimate concern. Cycling protocols and monitoring are appropriate for extended use.
The CJC-1295 + GHRP-2 Synergy
CJC-1295 (no-DAC) stimulates GH release through GHRH receptors. GHRP-2 stimulates GH release through ghrelin receptors. These are independent receptor systems converging on GH secretion through different intracellular pathways. Combining them produces synergistic GH elevation — substantially greater than either alone (Bowers et al., 1990). This is the same logic as CJC-1295 + ipamorelin, but GHRP-2 produces stronger raw GH responses.
What the research shows
HUMAN EVIDENCE
STUDYJournal of Clinical Endocrinology & Metabolism · 1993
GHRP-2 Stimulates GH Release in Healthy Adults
Alster DK, Bowers CY, Jaffe CA et al.
Human dose-finding study. GHRP-2 produced robust, dose-dependent GH responses. Confirmed cortisol and prolactin elevation alongside GH. Established the pharmacological profile that led to widespread research and diagnostic use.
STUDYJournal of Clinical Endocrinology & Metabolism · 1996
GHRP-2 as a Diagnostic Test for GH Deficiency
Ghigo E, Arvat E, Gianotti L et al.
Head-to-head comparison of GHRP-2 stimulation test vs. insulin tolerance test (ITT) for GH deficiency diagnosis. Comparable diagnostic accuracy. Basis for clinical diagnostic use in endocrinology.
GHRP-2 Combined with GHRH Produces Synergistic GH Release
Bowers CY, Sartor AO, Reynolds GA et al.
Established synergistic GH response when GHRP-2 (ghrelin receptor) is combined with GHRH (GHRH receptor). Mechanistic basis for the CJC-1295 + GHRP-2 combination stack.
✓Robust GH-releasing potency confirmed in multiple human studies
✓Cortisol and prolactin elevation alongside GH — dose-dependent and documented
✓Synergistic GH response with GHRH — mechanistic basis for CJC + GHRP-2 stack
✓Validated diagnostic tool for GH deficiency (GHRP-2 stimulation test)
✓Category 1 return in 2026 — compounding pharmacy access restored
?UNCERTAIN
?Long-term safety beyond diagnostic use durations
?Whether cortisol elevation with intermittent use is clinically significant long-term
?Optimal dosing and frequency for body composition goals
?Long-term body composition outcomes in controlled trials
?Head-to-head vs. ipamorelin for body composition outcomes
What the community reports
GHRP-2 has a long community track record — one of the older GH secretagogues, used in biohacker and bodybuilding circles since the early 2000s. The CJC-1295 + GHRP-2 stack is one of the most-documented GH optimization protocols in the space.
—Strong, reliable GH spikes — users who measure GH post-injection report consistently high peaks; often described as the most reliably potent secretagogue for raw GH elevation
—Sleep quality improvement — deep sleep enhancement; one of the first effects noticed
—Body composition over months — lean mass support and fat reduction with consistent training; gradual rather than dramatic
—Hunger increase — significant appetite stimulation, especially at higher doses; less pronounced than GHRP-6 but real
—GHRP-2 vs. ipamorelin: GHRP-2 often reported as producing stronger GH spikes with more cortisol and hunger
—GHRP-2 vs. GHRP-6: GHRP-2 described as the middle ground — stronger than ipamorelin, less hunger and cortisol than GHRP-6
Common misconceptions
"GHRP-2 and ipamorelin do the same thing."
REALITY
Both are GHSR agonists, but ipamorelin was specifically engineered for selectivity — minimal cortisol, minimal prolactin, minimal appetite. GHRP-2 is less selective and produces meaningful cortisol and prolactin elevation alongside stronger GH release. The choice is a trade-off: selectivity (ipamorelin) vs. raw GH potency (GHRP-2).
"More GHRP-2 produces linearly more GH."
REALITY
The GH response to GHRP-2 saturates — there's a ceiling above which higher doses don't produce proportionally more GH. The dose-response curve is steep at low doses and flattens significantly above 100–150 mcg in most studies. Stacking with CJC-1295 (different receptor) is more effective for amplifying GH than simply increasing GHRP-2 dose.
"The cortisol elevation is dangerous."
REALITY
The cortisol elevation from GHRP-2 is real and dose-dependent, but for intermittent use (1–3x daily), it's generally within physiological ranges and manageable. Long-term daily use with persistently elevated cortisol is a legitimate concern — cycling and monitoring are appropriate for extended protocols.
COMPARE
Ipamorelin — selective GHSR agonist with minimal cortisol/prolactin; cleaner long-term profile. GHRP-6 — stronger hunger and cortisol than GHRP-2; strongest raw GH of the class. CJC-1295 — the GHRH-receptor stack partner.
RECONSTITUTION CALCULATOR
EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN
AI COACH PREVIEW
I'm running CJC-1295 + GHRP-2. What dose and timing gets the best GH pulse?
For CJC-1295 no-DAC + GHRP-2, the protocol optimization comes down to three variables: dose, timing, and injection conditions. On dose: GHRP-2's GH response saturates above 100–150 mcg — there's no meaningful additional GH above that threshold, but you do get more cortisol and appetite. 100 mcg GHRP-2 is the standard starting point. CJC-1295 no-DAC: 100–200 mcg. These are injected simultaneously — they hit different receptor systems and the synergistic response is best when both are present at the same time. On timing: the strongest GH pulses come when you're in a state of low insulin and low somatostatin. This means: injecting on an empty stomach (wait at least 2 hours after eating, or fast), and avoiding high-carbohydrate or high-fat meals immediately after — both blunt GH. The before-bed injection is the most valuable: it amplifies the endogenous GH pulse that accompanies the onset of slow-wave sleep. Insulin is typically lowest at this time, somatostatin is low, and the pituitary is primed for GH secretion. If you're doing multiple daily injections (which some protocols do), the priority order is: before bed first, then pre-workout second if training in the morning, then morning on waking if doing 3x. The before-workout injection has the additional benefit of the GH pulse coinciding with the exercise-induced GH stimulus. Don't eat for at least 30 minutes post-injection if possible — again, insulin blunts the GH response. What's your current frequency? Once daily at bedtime vs. 2–3x daily produces meaningfully different IGF-1 elevation over an 8-week protocol, and the answer to which is better depends on what you're trying to optimize for.
CONTINUE IN THE APP
Open PepperLedger to build your GHRP-2 stack →
Free to join. No credit card. Ask the Coach about your GHRP-2 protocol once you're in.
Free to join · No credit card · 23-day Pro trial included